- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04784104
Comparison of Infraclavicular And Supraclavicular Block
Comparison of Infraclavicular and Supraclavicular Block Approaches in Ultrasound Guided Brachial Plexus Block
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
In this prospective single-blind study, patients will be divided into 2 groups with the closed envelope method. Patients will be taken to the block application room before the operation. Standard monitoring (pulse oximetry, noninvasive blood pressure, ECG) will be applied to the patients. Premedication will be provided with 1mg IV midazolam after peripheral vascular access. Blocks will be performed by an experienced anesthesiologist under the guidance of USG and evaluated by another anesthesiologist who is blind to the block technique. After the antisepsis of the area, a 22G 100 mm stimulator needle will be used in the infraclavicular approach and a 22G 50 mm in the supraclavicular block. Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture. 30 ml of 1:1 0.5% bupivacaine and 2% prilocaine plus 5 mcg adrenaline per ml will be used as local anesthetic mixture. The infraclavicular block will be applied by the lateral sagittal method under USG guidance. Supraclavicular block will be applied in the coronal oblique plane while the probe is placed on the clavicle. Following the blocks, the 5th, 10th, 15th, 20th, 25th, and 30th-minute sensory block levels, 10th, 20th, and 30th-minute motor block levels will be recorded. Sensory block level; Axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain). The motor block will be evaluated with a modified bromage scale: 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm.
Block success; At the 30th minute of LA application, the pinprick test will define the presence of insensibility or only a sense of touch in the musculocutaneous, radial, ulnar, median, cutaneous antebrachii nerves. If any of these nerves are not blocked, it will be considered a failed block.
Postoperative analgesia time; It will be considered as when the NRS(Numeric Rating Scale) is≥1.
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS scores at the 2nd, 6th, 12th, 24th hours.
Sensory (the time from local anesthetic injection until the patient fully perceives the upper limb) and motor (the time from local anesthetic injection until the patient's upper extremity regains full muscle strength) block time will be recorded as the block return time. Pain score during block application will be evaluated with the NRS. Block application time will be defined as the time from the moment the needle passes the skin until the local anesthetic is given and withdrawn. Block formation time will be defined as the time required to initiate anesthesia and analgesia in all 5 distal nerves. Patient and surgeon satisfaction will be evaluated as 1 = complete dissatisfaction, 2 = moderate satisfaction, 3 = full satisfaction, after the procedure. Patients will be followed up for 24 hours in terms of undesirable side effects, vascular puncture, hematoma, signs of LA toxicity, respiratory distress, pneumothorax, and horner syndrome. As rescue anesthesia, sedoanalgesia will be tried with remifentanil infusion, if it is not successful, general anesthesia will be started with a laryngeal mask. As postoperative analgesic regimen, patients will receive 3 x 1000 mg IV acetaminophen. As rescue analgesia, Tramadol 1 mg/kg IV will be ordered to be administered when the patient's NRS is 3 or more. The first time when the patient receives rescue analgesia and the total dose of rescue analgesia for the first 24 hours will be recorded.
Tipo de estudio
Inscripción (Anticipado)
Fase
- Fase 4
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Mehmet E Şen, MD
- Número de teléfono: +905436838272
- Correo electrónico: m_emre_sen@hotmail.com
Copia de seguridad de contactos de estudio
- Nombre: Zeki T Tekgül, Assoc Prof
- Número de teléfono: +905058554705
- Correo electrónico: zekitekgul@yahoo.com
Ubicaciones de estudio
-
-
Karabağlar
-
Izmir, Karabağlar, Pavo, 35170
- Izmir Bozyaka Training and Research Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 18-65 years old
- ASA I-II
- Patients scheduled for hand, wrist, and forearm surgery
Exclusion Criteria:
- Uncoordinated patients
- Having a disease that prevents sensory block evaluation,
- Have coagulopathy,
- Known allergies to drugs to be used,
- Those with anatomical disorders at the application points
- Pregnant patients,
- Patients under 18 years of age,
- Patients with known local anesthetic allergy,
- Patients diagnosed with sepsis and bacteriemia,
- Skin infection at the injection site.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Supraclaviculer block
The coronal oblique supraclavicular block will be applied to the first group with ultrasound guidance using a 22G 50 mm stimulator needle.
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine, 2 ml saline with 5 mcg adrenaline per ml.) Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.
|
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Otros nombres:
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Otros nombres:
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Otros nombres:
The blocks will be performed by an experienced anesthesiologist with a USG guidence.
|
|
Experimental: Infraclaviculer block
The lateral sagittal infraclavicular block will be applied to the second group with ultrasound guidance using a 22G 100 mm stimulator needle.
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine, 2 ml saline with 5 mcg adrenaline per ml.).
Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.
|
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Otros nombres:
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Otros nombres:
30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml.
(14 ml.
bupivacaine, 14 ml.
prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)
Otros nombres:
The blocks will be performed by an experienced anesthesiologist with USG guidence.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Block Formation Time
Periodo de tiempo: 30th minute pre-operatively
|
Block formation time will be defined as the time required to initiate anesthesia and analgesia in all 5 distal nerves.
|
30th minute pre-operatively
|
|
Block Application Time
Periodo de tiempo: During Block Application
|
Block application time will be defined as the time from the moment the needle passes the skin until the local anesthetic is given and withdrawn.
|
During Block Application
|
|
Block success
Periodo de tiempo: At the 30th minute of LA application
|
Block success; at the 30th minute of local anesthesic application, the pinprick test will define the presence of insensibility or only a sense of touch in the musculocutaneous, radial, ulnar, median, cutaneous antebrachii nerves.
If any of these nerves are not blocked, it will be considered a failed block.
|
At the 30th minute of LA application
|
|
Sensory Block Level 5th minute
Periodo de tiempo: 5th minute
|
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded.
(0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
|
5th minute
|
|
Sensory Block Level 10th minute
Periodo de tiempo: 10th minute
|
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded.
(0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
|
10th minute
|
|
Sensory Block Level 15th minute
Periodo de tiempo: 15th minute
|
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded.
(0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
|
15th minute
|
|
Sensory Block Level 20th minute
Periodo de tiempo: 20th minute
|
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded.
(0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
|
20th minute
|
|
Sensory Block Level 25th minute
Periodo de tiempo: 25th minute
|
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded.
(0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
|
25th minute
|
|
Sensory Block Level 30th minute
Periodo de tiempo: 30th minute
|
Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded.
(0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).
|
30th minute
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The Motor Block Level 10th minute
Periodo de tiempo: 10th minute
|
The motor block will be evaluated with a Modified Bromage Scale.
( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm.
)
|
10th minute
|
|
Postoperative Analgesia Time
Periodo de tiempo: 24 hours post-operatively
|
Postoperative analgesia time; It will be considered as when the NRS (Numeric Rating Scale) is≥1.
|
24 hours post-operatively
|
|
Pain Score Follow-up 2nd Hour
Periodo de tiempo: 2nd hour
|
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 2nd hour.
|
2nd hour
|
|
Block Return Time
Periodo de tiempo: 24 hours postoperatively
|
Sensory (the time from local anaesthetic injection until the patient fully perceives the upper limb) and motor (the time from local anaesthetic injection until the patient's upper extremity regains full muscle strength) block time will be recorded as the block return time.
|
24 hours postoperatively
|
|
Patient and Surgeon Satisfaction
Periodo de tiempo: Immediately after the surgery
|
Patient and surgeon satisfaction will be evaluated as 1 = complete dissatisfaction, 2 = moderate dissatisfaction, 3 = moderate satisfaction 4 =full satisfaction, after the procedure.
|
Immediately after the surgery
|
|
Undesirable Side Effects
Periodo de tiempo: 24 hours postoperatively
|
Patients will be followed up for 24 hours in terms of undesirable side effects, vascular puncture, hematoma, signs of LA toxicity, respiratory distress, pneumothorax, and horner syndrome.
|
24 hours postoperatively
|
|
The Rescue Analgesia
Periodo de tiempo: 24 hours postoperatively
|
As rescue analgesia, Tramadol 1 mg/kg IV will be ordered to be administered when the patient's NRS is 3 or more.
The first time when the patient receives rescue analgesia will be recorded.
|
24 hours postoperatively
|
|
24-Hour Total Opioid Consumption
Periodo de tiempo: 24 hours postoperatively
|
The total dose of rescue analgesia (Tramadol ) for the first 24 hours will be recorded.
|
24 hours postoperatively
|
|
Pain Score Follow-up 6th Hour
Periodo de tiempo: 6th Hour
|
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 6th hour.
|
6th Hour
|
|
Pain Score Follow-up 12th Hour
Periodo de tiempo: 12th Hour
|
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 12th hour.
|
12th Hour
|
|
Pain Score Follow-up 24th Hour
Periodo de tiempo: 24th Hour
|
Pain Score Follow-up; patients' pain scores will be recorded by checking their NRS (Numeric Rating Scale) scores at the 24th hour.
|
24th Hour
|
|
The Motor Block Level 20th minute
Periodo de tiempo: 20th minute
|
The motor block will be evaluated with a Modified Bromage Scale.
( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm.
)
|
20th minute
|
|
The Motor Block Level 30th minute
Periodo de tiempo: 30th minute
|
The motor block will be evaluated with a Modified Bromage Scale.
( 0: No blocks, he can lift his arm; 1: Arm is weak but active; 2: Arm is motionless but fingers are active; 3: Complete block, no movement in hand or arm.
)
|
30th minute
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Mehmet E Şen, MD, Izmir Bozyaka Training and Research Hospital
- Silla de estudio: Zeki T Tekgül, Assoc Prof, Izmir Bozyaka Training and Research Hospital
- Silla de estudio: Taşkın Altay, Assoc Prof, Izmir Bozyaka Training and Research Hospital
Publicaciones y enlaces útiles
Publicaciones Generales
- Gürkan Y, Hoşten T, Tekin M, Acar S, Solak M, Toker K. [Comparison of ultrasound-guided supraclavicular and infraclavicular approaches for brachial plexus blockade]. Agri. 2012;24(4):159-64. doi: 10.5505/agri.2012.38247. Turkish.
- Grape S, Pawa A, Weber E, Albrecht E. Retroclavicular vs supraclavicular brachial plexus block for distal upper limb surgery: a randomised, controlled, single-blinded trial. Br J Anaesth. 2019 Apr;122(4):518-524. doi: 10.1016/j.bja.2018.12.022. Epub 2019 Jan 31.
- Arcand G, Williams SR, Chouinard P, Boudreault D, Harris P, Ruel M, Girard F. Ultrasound-guided infraclavicular versus supraclavicular block. Anesth Analg. 2005 Sep;101(3):886-890. doi: 10.1213/01.ANE.0000159168.69934.CC.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Anticipado)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Procesos Patológicos
- Complicaciones Postoperatorias
- Dolor
- Manifestaciones neurológicas
- Dolor Postoperatorio
- Efectos fisiológicos de las drogas
- Agentes adrenérgicos
- Agentes neurotransmisores
- Mecanismos moleculares de acción farmacológica
- Depresores del sistema nervioso central
- Agentes Autonómicos
- Agentes del sistema nervioso periférico
- Agentes del sistema sensorial
- Anestésicos
- Agonistas alfa adrenérgicos
- Agonistas adrenérgicos
- Anestésicos Locales
- Agentes broncodilatadores
- Agentes antiasmáticos
- Agentes del sistema respiratorio
- Agonistas beta adrenérgicos
- Simpaticomiméticos
- Agentes vasoconstrictores
- Midriáticos
- Soluciones farmacéuticas
- Prilocaína
- Bupivacaína
- Epinefrina
- Racepinefrina
- Borato de epinefrilo
Otros números de identificación del estudio
- SupraInfraTez
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .